Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zibotentan in Microvascular Angina: Randomised Double-blind Placebo-controlled Crossover Trial
2018-004393-10Phase 2Unknown
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of zibotentan in microvascular angina (MVA) and None (2 arms), sponsored by NHS Greater Glasgow and Clyde. Primary endpoint: Exercise duration on Bruce protocol. Status: unknown.
02
Drugs
zibotentan
03
Conditions
microvascular angina (MVA)
Beyond the preview
Go deeper on 2018-004393-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004393-10.